Structure

Physi-Chem Properties

Molecular Weight:  572.37
Volume:  610.743
LogP:  5.65
LogD:  4.265
LogS:  -4.219
# Rotatable Bonds:  9
TPSA:  121.13
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.166
Synthetic Accessibility Score:  5.245
Fsp3:  0.794
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.813
MDCK Permeability:  7.617326446052175e-06
Pgp-inhibitor:  0.033
Pgp-substrate:  0.038
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.207
30% Bioavailability (F30%):  0.691

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.153
Plasma Protein Binding (PPB):  95.03458404541016%
Volume Distribution (VD):  0.456
Pgp-substrate:  3.6956117153167725%

ADMET: Metabolism

CYP1A2-inhibitor:  0.003
CYP1A2-substrate:  0.133
CYP2C19-inhibitor:  0.006
CYP2C19-substrate:  0.81
CYP2C9-inhibitor:  0.08
CYP2C9-substrate:  0.975
CYP2D6-inhibitor:  0.001
CYP2D6-substrate:  0.088
CYP3A4-inhibitor:  0.076
CYP3A4-substrate:  0.152

ADMET: Excretion

Clearance (CL):  3.664
Half-life (T1/2):  0.741

ADMET: Toxicity

hERG Blockers:  0.006
Human Hepatotoxicity (H-HT):  0.322
Drug-inuced Liver Injury (DILI):  0.043
AMES Toxicity:  0.005
Rat Oral Acute Toxicity:  0.597
Maximum Recommended Daily Dose:  0.957
Skin Sensitization:  0.717
Carcinogencity:  0.273
Eye Corrosion:  0.904
Eye Irritation:  0.211
Respiratory Toxicity:  0.972

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC120708

Natural Product ID:  NPC120708
Common Name*:   (25S)-(+)-12Alpha-Hydroxy-3Alpha-Malonyloxy-24-Methyllanosta-8,24(31)-Dien-26-Oic Acid
IUPAC Name:   (2S,6R)-6-[(3R,5R,10S,12S,13R,14S,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid
Synonyms:  
Standard InCHIKey:  HMOMGSPWDYKCAH-JJPOTAKPSA-N
Standard InCHI:  InChI=1S/C34H52O7/c1-19(21(3)30(39)40)9-10-20(2)22-13-16-33(7)23-11-12-25-31(4,5)27(41-29(38)18-28(36)37)14-15-32(25,6)24(23)17-26(35)34(22,33)8/h20-22,25-27,35H,1,9-18H2,2-8H3,(H,36,37)(H,39,40)/t20-,21+,22-,25+,26+,27-,32-,33+,34+/m1/s1
SMILES:  C=C(CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=C(C[C@@H]([C@]12C)O)[C@@]1(C)CC[C@H](C(C)(C)[C@@H]1CC3)OC(=O)CC(=O)O)[C@H](C)C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL444451
PubChem CID:   21581807
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8228 Piptoporus betulinus Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. PMID[11099232]
NPO8228 Piptoporus betulinus Species Fomitopsidaceae Eukaryota n.a. n.a. n.a. PMID[12932134]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus Inhibition = 65.0 % PMID[572813]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC120708 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9362 High Similarity NPC473514
0.9333 High Similarity NPC26888
0.9326 High Similarity NPC474889
0.9263 High Similarity NPC473788
0.9263 High Similarity NPC475558
0.9239 High Similarity NPC473648
0.9222 High Similarity NPC175628
0.9222 High Similarity NPC111585
0.9222 High Similarity NPC148414
0.9213 High Similarity NPC242864
0.9032 High Similarity NPC184848
0.9032 High Similarity NPC69548
0.9011 High Similarity NPC471896
0.8989 High Similarity NPC28252
0.8989 High Similarity NPC55309
0.898 High Similarity NPC475494
0.8936 High Similarity NPC327788
0.8901 High Similarity NPC474704
0.8901 High Similarity NPC475921
0.8889 High Similarity NPC159046
0.8889 High Similarity NPC233836
0.8889 High Similarity NPC187376
0.883 High Similarity NPC470016
0.883 High Similarity NPC317586
0.8817 High Similarity NPC473690
0.8817 High Similarity NPC471902
0.8817 High Similarity NPC287118
0.8804 High Similarity NPC469400
0.875 High Similarity NPC477813
0.8723 High Similarity NPC166906
0.871 High Similarity NPC471901
0.871 High Similarity NPC475416
0.871 High Similarity NPC23434
0.871 High Similarity NPC297265
0.8696 High Similarity NPC474570
0.8696 High Similarity NPC77168
0.8696 High Similarity NPC84271
0.8696 High Similarity NPC102414
0.8681 High Similarity NPC474684
0.8681 High Similarity NPC142361
0.8632 High Similarity NPC279974
0.8632 High Similarity NPC195715
0.8632 High Similarity NPC48330
0.8617 High Similarity NPC470224
0.8602 High Similarity NPC20388
0.8587 High Similarity NPC471724
0.8571 High Similarity NPC474970
0.8571 High Similarity NPC155011
0.8571 High Similarity NPC325594
0.8557 High Similarity NPC119036
0.8542 High Similarity NPC328162
0.8542 High Similarity NPC305483
0.8542 High Similarity NPC173272
0.8542 High Similarity NPC96859
0.8526 High Similarity NPC469406
0.8526 High Similarity NPC159410
0.8526 High Similarity NPC78580
0.8526 High Similarity NPC23621
0.8526 High Similarity NPC184006
0.8511 High Similarity NPC189520
0.85 High Similarity NPC96268
0.8495 Intermediate Similarity NPC57954
0.8495 Intermediate Similarity NPC213832
0.8485 Intermediate Similarity NPC296879
0.8485 Intermediate Similarity NPC471119
0.8478 Intermediate Similarity NPC96496
0.8454 Intermediate Similarity NPC320306
0.8438 Intermediate Similarity NPC162001
0.8438 Intermediate Similarity NPC45324
0.8438 Intermediate Similarity NPC205173
0.8438 Intermediate Similarity NPC210214
0.8438 Intermediate Similarity NPC222845
0.8438 Intermediate Similarity NPC23241
0.8438 Intermediate Similarity NPC469599
0.8421 Intermediate Similarity NPC470375
0.8421 Intermediate Similarity NPC86368
0.8421 Intermediate Similarity NPC170220
0.8421 Intermediate Similarity NPC470376
0.8421 Intermediate Similarity NPC141497
0.8421 Intermediate Similarity NPC107674
0.8404 Intermediate Similarity NPC44240
0.84 Intermediate Similarity NPC159442
0.84 Intermediate Similarity NPC55954
0.84 Intermediate Similarity NPC218513
0.8387 Intermediate Similarity NPC471722
0.8387 Intermediate Similarity NPC146937
0.8387 Intermediate Similarity NPC4309
0.8387 Intermediate Similarity NPC183546
0.8387 Intermediate Similarity NPC471900
0.837 Intermediate Similarity NPC73038
0.837 Intermediate Similarity NPC94755
0.837 Intermediate Similarity NPC72133
0.837 Intermediate Similarity NPC264127
0.8367 Intermediate Similarity NPC164349
0.8351 Intermediate Similarity NPC7124
0.8351 Intermediate Similarity NPC328371
0.8351 Intermediate Similarity NPC471153
0.8351 Intermediate Similarity NPC42042
0.8333 Intermediate Similarity NPC471720
0.8333 Intermediate Similarity NPC474922
0.8333 Intermediate Similarity NPC220974
0.8316 Intermediate Similarity NPC288833
0.8316 Intermediate Similarity NPC60755
0.8316 Intermediate Similarity NPC228784
0.8316 Intermediate Similarity NPC285184
0.8316 Intermediate Similarity NPC86266
0.8316 Intermediate Similarity NPC77099
0.8316 Intermediate Similarity NPC212301
0.8316 Intermediate Similarity NPC324341
0.8316 Intermediate Similarity NPC110657
0.8316 Intermediate Similarity NPC155120
0.8316 Intermediate Similarity NPC282616
0.8316 Intermediate Similarity NPC966
0.8316 Intermediate Similarity NPC470590
0.8298 Intermediate Similarity NPC54689
0.8298 Intermediate Similarity NPC128496
0.8298 Intermediate Similarity NPC1015
0.8298 Intermediate Similarity NPC31985
0.8283 Intermediate Similarity NPC477521
0.8283 Intermediate Similarity NPC476299
0.8283 Intermediate Similarity NPC474012
0.8283 Intermediate Similarity NPC327431
0.8283 Intermediate Similarity NPC94906
0.8283 Intermediate Similarity NPC316964
0.828 Intermediate Similarity NPC269360
0.828 Intermediate Similarity NPC33768
0.828 Intermediate Similarity NPC134197
0.828 Intermediate Similarity NPC167877
0.828 Intermediate Similarity NPC264005
0.8265 Intermediate Similarity NPC43747
0.8265 Intermediate Similarity NPC141401
0.8265 Intermediate Similarity NPC108078
0.8265 Intermediate Similarity NPC253586
0.8265 Intermediate Similarity NPC26413
0.8252 Intermediate Similarity NPC472218
0.8252 Intermediate Similarity NPC472219
0.8252 Intermediate Similarity NPC195708
0.8252 Intermediate Similarity NPC472217
0.8247 Intermediate Similarity NPC318282
0.8247 Intermediate Similarity NPC469329
0.8247 Intermediate Similarity NPC174948
0.8247 Intermediate Similarity NPC30677
0.8247 Intermediate Similarity NPC469995
0.8247 Intermediate Similarity NPC180557
0.8247 Intermediate Similarity NPC263347
0.8247 Intermediate Similarity NPC37787
0.8247 Intermediate Similarity NPC173875
0.8247 Intermediate Similarity NPC88310
0.8247 Intermediate Similarity NPC473415
0.8242 Intermediate Similarity NPC471037
0.8235 Intermediate Similarity NPC278628
0.8235 Intermediate Similarity NPC231530
0.8229 Intermediate Similarity NPC206810
0.8222 Intermediate Similarity NPC473420
0.8218 Intermediate Similarity NPC470310
0.8218 Intermediate Similarity NPC222153
0.8211 Intermediate Similarity NPC111110
0.8211 Intermediate Similarity NPC113989
0.8211 Intermediate Similarity NPC169933
0.8211 Intermediate Similarity NPC473269
0.8211 Intermediate Similarity NPC477149
0.8211 Intermediate Similarity NPC477147
0.8211 Intermediate Similarity NPC86372
0.8211 Intermediate Similarity NPC120840
0.8211 Intermediate Similarity NPC474728
0.8211 Intermediate Similarity NPC470589
0.8211 Intermediate Similarity NPC172361
0.8211 Intermediate Similarity NPC126369
0.8208 Intermediate Similarity NPC472926
0.82 Intermediate Similarity NPC115899
0.82 Intermediate Similarity NPC75941
0.8191 Intermediate Similarity NPC143767
0.8191 Intermediate Similarity NPC328313
0.8191 Intermediate Similarity NPC97884
0.8191 Intermediate Similarity NPC53911
0.8191 Intermediate Similarity NPC294480
0.8191 Intermediate Similarity NPC131470
0.8191 Intermediate Similarity NPC472220
0.8182 Intermediate Similarity NPC186810
0.8182 Intermediate Similarity NPC48647
0.8182 Intermediate Similarity NPC16911
0.8182 Intermediate Similarity NPC472028
0.8182 Intermediate Similarity NPC477854
0.8182 Intermediate Similarity NPC78427
0.8173 Intermediate Similarity NPC265655
0.8173 Intermediate Similarity NPC218853
0.8173 Intermediate Similarity NPC472216
0.8173 Intermediate Similarity NPC284828
0.8173 Intermediate Similarity NPC173905
0.8173 Intermediate Similarity NPC5475
0.8172 Intermediate Similarity NPC212843
0.8172 Intermediate Similarity NPC2783
0.8172 Intermediate Similarity NPC6979
0.8172 Intermediate Similarity NPC12774
0.8163 Intermediate Similarity NPC471777
0.8163 Intermediate Similarity NPC98874
0.8163 Intermediate Similarity NPC327179
0.8163 Intermediate Similarity NPC132824
0.8163 Intermediate Similarity NPC13949
0.8163 Intermediate Similarity NPC95565

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC120708 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8421 Intermediate Similarity NPD6399 Phase 3
0.8152 Intermediate Similarity NPD4786 Approved
0.8125 Intermediate Similarity NPD8035 Phase 2
0.8125 Intermediate Similarity NPD8034 Phase 2
0.8125 Intermediate Similarity NPD6411 Approved
0.8065 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8058 Intermediate Similarity NPD5739 Approved
0.8058 Intermediate Similarity NPD6402 Approved
0.8058 Intermediate Similarity NPD7128 Approved
0.8058 Intermediate Similarity NPD6675 Approved
0.7959 Intermediate Similarity NPD7748 Approved
0.7935 Intermediate Similarity NPD3667 Approved
0.7917 Intermediate Similarity NPD6101 Approved
0.7917 Intermediate Similarity NPD5328 Approved
0.7917 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7905 Intermediate Similarity NPD6899 Approved
0.7905 Intermediate Similarity NPD6881 Approved
0.7905 Intermediate Similarity NPD7320 Approved
0.79 Intermediate Similarity NPD6083 Phase 2
0.79 Intermediate Similarity NPD6084 Phase 2
0.7879 Intermediate Similarity NPD5695 Phase 3
0.785 Intermediate Similarity NPD8130 Phase 1
0.783 Intermediate Similarity NPD6373 Approved
0.783 Intermediate Similarity NPD6372 Approved
0.7818 Intermediate Similarity NPD7115 Discovery
0.781 Intermediate Similarity NPD5701 Approved
0.781 Intermediate Similarity NPD5697 Approved
0.7789 Intermediate Similarity NPD3618 Phase 1
0.7778 Intermediate Similarity NPD8297 Approved
0.7757 Intermediate Similarity NPD7290 Approved
0.7757 Intermediate Similarity NPD6883 Approved
0.7757 Intermediate Similarity NPD7102 Approved
0.7755 Intermediate Similarity NPD7515 Phase 2
0.7755 Intermediate Similarity NPD6079 Approved
0.7723 Intermediate Similarity NPD7902 Approved
0.7685 Intermediate Similarity NPD6847 Approved
0.7685 Intermediate Similarity NPD6869 Approved
0.7685 Intermediate Similarity NPD6649 Approved
0.7685 Intermediate Similarity NPD6617 Approved
0.7685 Intermediate Similarity NPD6650 Approved
0.7664 Intermediate Similarity NPD6013 Approved
0.7664 Intermediate Similarity NPD6012 Approved
0.7664 Intermediate Similarity NPD6014 Approved
0.7647 Intermediate Similarity NPD7638 Approved
0.7629 Intermediate Similarity NPD6672 Approved
0.7629 Intermediate Similarity NPD5737 Approved
0.7615 Intermediate Similarity NPD6882 Approved
0.7604 Intermediate Similarity NPD6409 Approved
0.7604 Intermediate Similarity NPD5330 Approved
0.7604 Intermediate Similarity NPD6684 Approved
0.7604 Intermediate Similarity NPD7521 Approved
0.7604 Intermediate Similarity NPD7334 Approved
0.7604 Intermediate Similarity NPD7146 Approved
0.7573 Intermediate Similarity NPD7640 Approved
0.7573 Intermediate Similarity NPD7639 Approved
0.757 Intermediate Similarity NPD6011 Approved
0.7549 Intermediate Similarity NPD4755 Approved
0.7523 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5779 Approved
0.75 Intermediate Similarity NPD5778 Approved
0.75 Intermediate Similarity NPD4202 Approved
0.7476 Intermediate Similarity NPD5696 Approved
0.7473 Intermediate Similarity NPD6117 Approved
0.7451 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD5222 Approved
0.7451 Intermediate Similarity NPD5221 Approved
0.7451 Intermediate Similarity NPD4697 Phase 3
0.7449 Intermediate Similarity NPD6903 Approved
0.7449 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7426 Intermediate Similarity NPD7900 Approved
0.7426 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD5279 Phase 3
0.7404 Intermediate Similarity NPD5286 Approved
0.7404 Intermediate Similarity NPD4700 Approved
0.7404 Intermediate Similarity NPD4696 Approved
0.7404 Intermediate Similarity NPD5285 Approved
0.74 Intermediate Similarity NPD7637 Suspended
0.7396 Intermediate Similarity NPD3665 Phase 1
0.7396 Intermediate Similarity NPD3668 Phase 3
0.7396 Intermediate Similarity NPD3133 Approved
0.7396 Intermediate Similarity NPD3666 Approved
0.7391 Intermediate Similarity NPD6116 Phase 1
0.7379 Intermediate Similarity NPD5173 Approved
0.7374 Intermediate Similarity NPD4753 Phase 2
0.7363 Intermediate Similarity NPD6942 Approved
0.7363 Intermediate Similarity NPD7339 Approved
0.7353 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.734 Intermediate Similarity NPD7525 Registered
0.7312 Intermediate Similarity NPD6118 Approved
0.7312 Intermediate Similarity NPD6115 Approved
0.7312 Intermediate Similarity NPD6114 Approved
0.7312 Intermediate Similarity NPD6697 Approved
0.7308 Intermediate Similarity NPD4225 Approved
0.7304 Intermediate Similarity NPD6319 Approved
0.7264 Intermediate Similarity NPD5224 Approved
0.7264 Intermediate Similarity NPD5226 Approved
0.7264 Intermediate Similarity NPD4633 Approved
0.7264 Intermediate Similarity NPD5225 Approved
0.7264 Intermediate Similarity NPD5211 Phase 2
0.7257 Intermediate Similarity NPD6868 Approved
0.7257 Intermediate Similarity NPD6274 Approved
0.7253 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7245 Intermediate Similarity NPD6098 Approved
0.7245 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD5281 Approved
0.7228 Intermediate Similarity NPD5284 Approved
0.7228 Intermediate Similarity NPD6050 Approved
0.7227 Intermediate Similarity NPD8293 Discontinued
0.7222 Intermediate Similarity NPD6008 Approved
0.7217 Intermediate Similarity NPD7100 Approved
0.7217 Intermediate Similarity NPD7101 Approved
0.7203 Intermediate Similarity NPD7492 Approved
0.72 Intermediate Similarity NPD6904 Approved
0.72 Intermediate Similarity NPD6080 Approved
0.72 Intermediate Similarity NPD6673 Approved
0.7196 Intermediate Similarity NPD5175 Approved
0.7196 Intermediate Similarity NPD5174 Approved
0.7182 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5223 Approved
0.7167 Intermediate Similarity NPD7736 Approved
0.7155 Intermediate Similarity NPD6059 Approved
0.7155 Intermediate Similarity NPD6054 Approved
0.7143 Intermediate Similarity NPD6616 Approved
0.713 Intermediate Similarity NPD6335 Approved
0.713 Intermediate Similarity NPD5141 Approved
0.7129 Intermediate Similarity NPD5692 Phase 3
0.7117 Intermediate Similarity NPD4634 Approved
0.7103 Intermediate Similarity NPD7632 Discontinued
0.7097 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD6909 Approved
0.7094 Intermediate Similarity NPD6908 Approved
0.7083 Intermediate Similarity NPD5369 Approved
0.7083 Intermediate Similarity NPD7078 Approved
0.708 Intermediate Similarity NPD4632 Approved
0.7064 Intermediate Similarity NPD4767 Approved
0.7064 Intermediate Similarity NPD4768 Approved
0.7059 Intermediate Similarity NPD5694 Approved
0.7053 Intermediate Similarity NPD7645 Phase 2
0.7043 Intermediate Similarity NPD6317 Approved
0.7043 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD4754 Approved
0.7034 Intermediate Similarity NPD6370 Approved
0.7019 Intermediate Similarity NPD5210 Approved
0.7019 Intermediate Similarity NPD4629 Approved
0.701 Intermediate Similarity NPD4223 Phase 3
0.701 Intermediate Similarity NPD4221 Approved
0.7 Intermediate Similarity NPD6412 Phase 2
0.6983 Remote Similarity NPD6313 Approved
0.6983 Remote Similarity NPD6314 Approved
0.6979 Remote Similarity NPD4748 Discontinued
0.697 Remote Similarity NPD5329 Approved
0.6961 Remote Similarity NPD5207 Approved
0.6949 Remote Similarity NPD6015 Approved
0.6949 Remote Similarity NPD6016 Approved
0.6947 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6939 Remote Similarity NPD5362 Discontinued
0.6939 Remote Similarity NPD4788 Approved
0.6937 Remote Similarity NPD4729 Approved
0.6937 Remote Similarity NPD4730 Approved
0.6937 Remote Similarity NPD5128 Approved
0.6931 Remote Similarity NPD5208 Approved
0.6923 Remote Similarity NPD6001 Approved
0.6907 Remote Similarity NPD4692 Approved
0.6907 Remote Similarity NPD4139 Approved
0.69 Remote Similarity NPD5280 Approved
0.69 Remote Similarity NPD4694 Approved
0.69 Remote Similarity NPD5690 Phase 2
0.6897 Remote Similarity NPD6009 Approved
0.6893 Remote Similarity NPD5693 Phase 1
0.6891 Remote Similarity NPD5988 Approved
0.6875 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6869 Remote Similarity NPD4197 Approved
0.6863 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6863 Remote Similarity NPD6051 Approved
0.6848 Remote Similarity NPD4808 Clinical (unspecified phase)
0.6848 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6842 Remote Similarity NPD6053 Discontinued
0.6837 Remote Similarity NPD6435 Approved
0.6837 Remote Similarity NPD4269 Approved
0.6837 Remote Similarity NPD4270 Approved
0.6833 Remote Similarity NPD7604 Phase 2
0.6833 Remote Similarity NPD8328 Phase 3
0.6832 Remote Similarity NPD3573 Approved
0.6829 Remote Similarity NPD7319 Approved
0.6814 Remote Similarity NPD5251 Approved
0.6814 Remote Similarity NPD5247 Approved
0.6814 Remote Similarity NPD5248 Approved
0.6814 Remote Similarity NPD5249 Phase 3
0.6814 Remote Similarity NPD5250 Approved
0.6807 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6807 Remote Similarity NPD5983 Phase 2
0.6796 Remote Similarity NPD5785 Approved
0.6786 Remote Similarity NPD5168 Approved
0.6783 Remote Similarity NPD8133 Approved
0.6771 Remote Similarity NPD3617 Approved
0.6768 Remote Similarity NPD7154 Phase 3
0.6768 Remote Similarity NPD6695 Phase 3
0.6754 Remote Similarity NPD5217 Approved
0.6754 Remote Similarity NPD5216 Approved
0.6754 Remote Similarity NPD5215 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data